Related Experiment Video
Updated: Jul 2, 2026
12:27
The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 3, 2014
Acrolein-induced MUC5ac expression in rat airways
M T Borchers1, S E Wert, G D Leikauf
1Department of Environmental Health, University of Cincinnati 45267, USA.
The American Journal of Physiology
|May 12, 1998
Summary
Acrolein exposure increases MUC5ac mucin expression, leading to mucus hypersecretion in airways. This suggests MUC5ac plays a key role in aldehyde-induced mucus production, relevant to COPD.
Area of Science:
- Toxicology
- Pulmonary Medicine
- Molecular Biology
Background:
- Acrolein, present in smog and smoke, causes airway issues like mucus hypersecretion.
- Chronic mucus hypersecretion is a hallmark of chronic obstructive pulmonary disease (COPD).
Purpose of the Study:
- To investigate if acrolein exposure alters mucin gene expression (MUC2, MUC5ac).
- To correlate changes in mucin gene expression with histological signs of mucus hypersecretion.
Main Methods:
- Rats were exposed to acrolein (3.0 ppm) for 2 weeks.
- Tracheal and lung tissues were analyzed for MUC2 and MUC5ac mRNA via RT-PCR.
- Alcian blue staining and immunohistochemistry assessed mucin glycoproteins and protein levels.
Main Results:
- Acrolein exposure rapidly increased MUC5ac mRNA and protein in the trachea.
- Lung MUC5ac expression and mucin content increased with delayed kinetics.
- MUC2 mRNA levels remained unchanged in both trachea and lung.
Conclusions:
- Acrolein-induced mucus hypersecretion is primarily mediated by increased MUC5ac expression, not MUC2.
- Elevated MUC5ac may contribute to the mucus hypersecretion observed in COPD.
